Q64010 (CRK_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 115.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Adapter molecule crk Alternative name(s): Proto-oncogene c-Crk p38 | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus |
Protein attributes
| Sequence length | 304 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | The Crk-I and Crk-II forms differ in their biological activities. Crk-II has less transforming activity than Crk-I. Crk-II mediates attachment-induced MAPK8 activation, membrane ruffling and cell motility in a Rac-dependent manner. Involved in phagocytosis of apoptotic cells and cell motility via its interaction with DOCK1 and DOCK4. May regulate the EFNA5-EPHA3 signaling. |
| Subunit structure | Interacts with ABL1, C3G, SOS, MAP4K1 and MAPK8 via its first SH3 domain. Interacts (via SH2 domain) with BCAR1, CBL, CBLB, PXN, IRS4 and GAB1 upon stimulus-induced tyrosine phosphorylation. Interacts (via SH2 domain) with several tyrosine-phosphorylated growth factor receptors such as EGFR and INSR. Isoform Crk-II (via SH2 domain) interacts with PDGFRA (tyrosine phosphorylated) and PDGFRB (tyrosine phosphorylated). Interacts with DOCK1, DOCK4, C3G and EPS15 via its SH3 domain. Interacts with SHB By similarity. Interacts with PEAK1 By similarity. Interacts with DOCK3. Interacts with REPS1 and DDEF1/ASAP1 via its SH3 domain. Interacts with FASLG. Isoform Crk-II interacts with KIT. Interacts with EPHA3 (phosphorylated); mediates EFNA5-EPHA3 signaling through RHOA GTPase activation. Interacts with FLT4 (tyrosine-phosphorylated). Part of a collagen stimulated complex involved in cell migration composed of CDC42, CRK, TNK2 and BCAR1/p130cas By similarity. Interacts with FLT1 (tyrosine-phosphorylated). Interacts (via SH2 domain) with the 'Tyr-9' phosphorylated form of PDPK1 By similarity. Ref.3 Ref.4 Ref.5 Ref.6 Ref.7 Ref.8 Ref.9 Ref.10 |
| Subcellular location | Cytoplasm By similarity. Cell membrane By similarity. Note: Translocated to the plasma membrane upon cell adhesion By similarity. |
| Tissue specificity | Ubiquitous. |
| Domain | The C-terminal SH3 domain function as a negative modulator for transformation and the N-terminal SH3 domain appears to function as a positive regulator for transformation By similarity. The SH2 domain mediates interaction with tyrosine phosphorylated proteins. Mediates interaction with SHB. |
| Post-translational modification | Isoform Crk-II is phosphorylated by KIT. Phosphorylated on Tyr-221 upon cell adhesion. Results in the negative regulation of the association with SH2- and SH3-binding partners, possibly by the formation of an intramolecular interaction of phosphorylated Tyr-221 with the SH2 domain. This leads finally to the down-regulation of the Crk signaling pathway. Ref.3 Ref.9 Ref.11 Ref.12 Ref.13 |
| Sequence similarities | Belongs to the CRK family. Contains 1 SH2 domain. Contains 2 SH3 domains. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cell membrane Cytoplasm Membrane |
| Coding sequence diversity | Alternative splicing |
| Disease | Proto-oncogene |
| Domain | Repeat SH2 domain SH3 domain |
| PTM | Acetylation Phosphoprotein |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological process | ephrin receptor signaling pathway Inferred from sequence or structural similarity. Source: UniProtKB regulation of Rho GTPase activityInferred from sequence or structural similarity. Source: UniProtKB regulation of actin cytoskeleton organizationInferred from sequence or structural similarity. Source: UniProtKB |
| Cellular component | plasma membrane Inferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | SH3/SH2 adaptor activity Inferred from physical interaction. Source: BHF-UCL ephrin receptor bindingInferred from physical interaction Ref.8. Source: UniProtKB protein phosphorylated amino acid bindingInferred from direct assay. Source: MGI |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform Crk-II (identifier: Q64010-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform Crk-I (identifier: Q64010-2) The sequence of this isoform differs from the canonical sequence as follows: 205-304: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed By similarity | ||||||||||||||||||||||||||||||
| Chain | 2 – 304 | 303 | Adapter molecule crk | PRO_0000079352 | |||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||
| Domain | 13 – 118 | 106 | SH2 | ||||||||||||||||||||||||||||||
| Domain | 132 – 192 | 61 | SH3 1 | ||||||||||||||||||||||||||||||
| Domain | 237 – 296 | 60 | SH3 2 | ||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||
| Modified residue | 2 | 1 | N-acetylalanine By similarity | ||||||||||||||||||||||||||||||
| Modified residue | 41 | 1 | Phosphoserine Ref.11 | ||||||||||||||||||||||||||||||
| Modified residue | 42 | 1 | Phosphothreonine Ref.13 | ||||||||||||||||||||||||||||||
| Modified residue | 74 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||||
| Modified residue | 83 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||||
| Modified residue | 136 | 1 | Phosphotyrosine By similarity | ||||||||||||||||||||||||||||||
| Modified residue | 221 | 1 | Phosphotyrosine; by ABL1 Ref.3 Ref.12 | ||||||||||||||||||||||||||||||
| Modified residue | 239 | 1 | Phosphotyrosine By similarity | ||||||||||||||||||||||||||||||
| Modified residue | 251 | 1 | Phosphotyrosine By similarity | ||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||
| Alternative sequence | 205 – 304 | 100 | Missing in isoform Crk-I. | VSP_004174 | |||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||
| Beta strand | 136 – 141 | 6 | |||||||||||||||||||||||||||||||
| Beta strand | 158 – 163 | 6 | |||||||||||||||||||||||||||||||
| Beta strand | 165 – 173 | 9 | |||||||||||||||||||||||||||||||
| Beta strand | 179 – 183 | 5 | |||||||||||||||||||||||||||||||
| Helix | 184 – 186 | 3 | |||||||||||||||||||||||||||||||
| Beta strand | 238 – 244 | 7 | |||||||||||||||||||||||||||||||
| Beta strand | 252 – 254 | 3 | |||||||||||||||||||||||||||||||
| Beta strand | 262 – 268 | 7 | |||||||||||||||||||||||||||||||
| Beta strand | 271 – 273 | 3 | |||||||||||||||||||||||||||||||
| Beta strand | 275 – 279 | 5 | |||||||||||||||||||||||||||||||
| Beta strand | 282 – 286 | 5 | |||||||||||||||||||||||||||||||
| Helix | 288 – 290 | 3 | |||||||||||||||||||||||||||||||
| Beta strand | 291 – 294 | 4 | |||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The C-terminal SH3 domain of the mouse c-Crk protein negatively regulates tyrosine-phosphorylation of Crk associated p130 in rat 3Y1 cells." Ogawa S., Toyoshima H., Kozutsumi H., Hagiwara K., Sakai R., Tanaka T., Hirano N., Mano H., Yazaki Y., Hirai H. Oncogene 9:1669-1678(1994) [PubMed: 8183562] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS CRK-I AND CRK-II). Tissue: Liver. |
| [2] | "The transcriptional landscape of the mammalian genome." Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. Hayashizaki Y.Science 309:1559-1563(2005) [PubMed: 16141072] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM CRK-II). Strain: C57BL/6J. Tissue: Skin. |
| [3] | "c-Abl kinase regulates the protein binding activity of c-Crk." Feller S.M., Knudsen B., Hanafusa H. EMBO J. 13:2341-2351(1994) [PubMed: 8194526] [Abstract] Cited for: PHOSPHORYLATION AT TYR-221, INTERACTION WITH ABL1. |
| [4] | "An eps homology (EH) domain protein that binds to the ral-GTPase target, RalBP1." Yamaguchi A., Urano T., Goi T., Feig L.A. J. Biol. Chem. 272:31230-31234(1997) [PubMed: 9395447] [Abstract] Cited for: INTERACTION WITH REPS1. Tissue: Muscle. |
| [5] | "Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules." Ito N., Wernstedt C., Engstrom U., Claesson-Welsh L. J. Biol. Chem. 273:23410-23418(1998) [PubMed: 9722576] [Abstract] Cited for: INTERACTION WITH FLT1. |
| [6] | "ASAP1, a phospholipid-dependent arf GTPase-activating protein that associates with and is phosphorylated by Src." Brown M.T., Andrade J., Radhakrishna H., Donaldson J.G., Cooper J.A., Randazzo P.A. Mol. Cell. Biol. 18:7038-7051(1998) [PubMed: 9819391] [Abstract] Cited for: INTERACTION WITH DDEF1/ASAP1. |
| [7] | "Isolation and characterization of novel presenilin binding protein." Kashiwa A., Yoshida H., Lee S., Paladino T., Liu Y., Chen Q., Dargusch R., Schubert D., Kimura H. J. Neurochem. 75:109-116(2000) [PubMed: 10854253] [Abstract] Cited for: INTERACTION WITH DOCK3. Tissue: Brain. |
| [8] | "Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling." Lawrenson I.D., Wimmer-Kleikamp S.H., Lock P., Schoenwaelder S.M., Down M., Boyd A.W., Alewood P.F., Lackmann M. J. Cell Sci. 115:1059-1072(2002) [PubMed: 11870224] [Abstract] Cited for: INTERACTION WITH EPHA3. |
| [9] | "Identification of Tyr900 in the kinase domain of c-Kit as a Src-dependent phosphorylation site mediating interaction with c-Crk." Lennartsson J., Wernstedt C., Engstrom U., Hellman U., Ronnstrand L. Exp. Cell Res. 288:110-118(2003) [PubMed: 12878163] [Abstract] Cited for: INTERACTION WITH KIT, MASS SPECTROMETRY, PHOSPHORYLATION. |
| [10] | "The roles of Cbl-b and c-Cbl in insulin-stimulated glucose transport." Liu J., DeYoung S.M., Hwang J.B., O'Leary E.E., Saltiel A.R. J. Biol. Chem. 278:36754-36762(2003) [PubMed: 12842890] [Abstract] Cited for: INTERACTION WITH CBLB. |
| [11] | "Phosphoproteomic analysis of the developing mouse brain." Ballif B.A., Villen J., Beausoleil S.A., Schwartz D., Gygi S.P. Mol. Cell. Proteomics 3:1093-1101(2004) [PubMed: 15345747] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41, MASS SPECTROMETRY. Tissue: Embryonic brain. |
| [12] | "Large-scale identification and evolution indexing of tyrosine phosphorylation sites from murine brain." Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P. J. Proteome Res. 7:311-318(2008) [PubMed: 18034455] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-221, MASS SPECTROMETRY. Tissue: Brain. |
| [13] | "Large-scale phosphorylation analysis of mouse liver." Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007) [PubMed: 17242355] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-42, MASS SPECTROMETRY. Tissue: Liver. |
| [14] | "Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk." Wu X., Knudsen B., Feller S.M., Zheng J., Sali A., Cowburn D., Hanafusa H., Kuriyan J. Structure 3:215-226(1995) [PubMed: 7735837] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 134-190. |
| [15] | "Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors." Nguyen J.T., Turck C.W., Cohen F.E., Zuckermann R.N., Lim W.A. Science 282:2088-2092(1998) [PubMed: 9851931] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 133-191. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | S72408 mRNA. Translation: AAB30755.1. AK028488 mRNA. Translation: BAC25976.1. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IPI | IPI00307991. IPI00345994. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RefSeq | NP_598417.2. NM_133656.4. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UniGene | Mm.280125. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ProteinModelPortal | Q64010. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SMR | Q64010. Positions 1-304. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IntAct | Q64010. 21 interactions. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| STRING | Q64010. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PhosphoSite | Q64010. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PRIDE | Q64010. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ensembl | ENSMUST00000017920; ENSMUSP00000017920; ENSMUSG00000017776. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GeneID | 12928. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| KEGG | mmu:12928. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CTD | 1398. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MGI | MGI:88508. Crk. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOGENOM | HBG314739. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOVERGEN | HBG105616. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| InParanoid | Q64010. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| OrthoDB | EOG4WWRK5. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PhylomeDB | Q64010. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ArrayExpress | Q64010. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Bgee | Q64010. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CleanEx | MM_CRK. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Genevestigator | Q64010. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GermOnline | ENSMUSG00000017776. Mus musculus. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| InterPro | IPR000980. SH2. IPR011511. SH3_2. IPR001452. SH3_domain. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gene3D | G3DSA:3.30.505.10. SH2. 1 hit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| KO | K04438. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pfam | PF00017. SH2. 1 hit. PF00018. SH3_1. 1 hit. PF07653. SH3_2. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PRINTS | PR00401. SH2DOMAIN. PR00452. SH3DOMAIN. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SMART | SM00252. SH2. 1 hit. SM00326. SH3. 2 hits. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SUPFAM | SSF50044. SH3. 2 hits. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PROSITE | PS50001. SH2. 1 hit. PS50002. SH3. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NextBio | 282592. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | CRK_MOUSE | ||||||||
| Accession | Primary (citable) accession number: Q64010 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with